Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to ...

Each year, seasonal flu sickens about 1 billion people worldwide and causes approximately 290,000 to 650,000 respiratory ...

Influenza virus is an infectious agent belonging to ... influenza in a mouse model. Results were dependent on drug, dosage and infection route but highlighted the need to explore further options ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...

As schools reopen, the Korea Disease Control and Prevention Agency (KDCA) reports an uptick in flu cases following a recent ...

Results showed that in a preclinical model, the two most common FDA-approved ... mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milk, Nature Microbiology ...

The first research programs attempting to develop an inactivated influenza vaccine, outside of the USSR, were conducted in England and in the USA at about the same time. However, it was at the ...